CompaniesHeart Metabolics

Heart Metabolics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

35

By Phase

PHASE2: 1PHASE3: 1

By Status

TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
Today
NCT02862600
Hover over trial bars to see details

Recent Trials

NCT02862600Lead Sponsor
Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
PHASE2Terminated
35 participants
Started: Aug 1, 2016 · Completed: May 22, 2017
NCT02431221Lead Sponsor
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
PHASE3Withdrawn